A major Swedish study of 247,420 individuals with attention-deficit/hyperactivity disorder (ADHD) has found that medication ...

DELAWARE, DE, UNITED STATES, July 4, 2025 /EINPresswire.com/ -- The global Attention Deficit Hyperactivity Disorder (ADHD) market is anticipated to reach USD 18.3 billion by 2025, as a result of ...

The U.S. Food and Drug Administration is revising the labeling of all extended-release attention-deficit/hyperactivity ...

The U.S. Food and Drug Administration is revising the labeling of all extended-release attention-deficit/hyperactivity ...

GPs in New South Wales who have undergone training will be able to resupply ADHD medication to patients who have already been diagnosed with the condition.

The Food and Drug Administration is revising the labeling of all extended-release stimulants used to treat attention-deficit hyperactivity disorder to include warnings about the risk of weight loss ...

You likely are accustomed to encountering a range of menus in daily life, but there is one that may be new to you: a dopamine ...

Attention-deficit/hyperactivity disorder (ADHD) medications remain associated with a reduced risk for various real-world ...

When combined, a subjective list of common childhood behaviors (fidgeting, losing things, distractibility, not following ...

Labels of all extended-release stimulants indicated for ADHD -- including certain formulations of amphetamine and ...